Trials / Completed
CompletedNCT02111928
NovaTears® Eye Drops Observational Study
NovaTears® Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Novaliq GmbH · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This observational pilot-study is intended to collect outcome data from a cohort of 30 patients suffering from hyper-evaporative dry eye disease who are treated with the medical device NovaTears® eye drops for a duration of 5 to 7 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NovaTears® Eye Drops | Topical eye drops for lubrication of the ocular surface |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-04-11
- Last updated
- 2015-10-06
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02111928. Inclusion in this directory is not an endorsement.